Mesenchymal stem cells and potential applications in treating ocular disease.
about
Mesenchymal stem cells for treating ocular surface diseasesInfluence of Iron Oxide Nanoparticles on Innate and Genetically Modified Secretion Profiles of Mesenchymal Stem CellsTherapeutic effect of bone marrow mesenchymal stem cells on laser-induced retinal injury in miceEfficacy of topical mesenchymal stem cell therapy in the treatment of experimental dry eye syndrome modelPotential role of intravitreal human placental stem cell implants in inhibiting progression of diabetic retinopathy in type 2 diabetes: neuroprotective growth factors in the vitreousA comparative study on the transplantation of different concentrations of human umbilical mesenchymal cells into diabetic rats.Thermally labile components of aqueous humor potently induce osteogenic potential in adipose-derived mesenchymal stem cells.An ex vivo gene therapy approach in X-linked retinoschisis.Organ repair and regeneration: an overview.Progenitor cells for ocular surface regenerative therapy.Next-generation therapeutic solutions for age-related macular degeneration.Temporal profiling of the growth and multi-lineage potentiality of adipose tissue-derived mesenchymal stem cells cell-sheets.Basic fibroblast growth factor expression is implicated in mesenchymal stem cells response to light-induced retinal injury.Limbal stem cell disease: Treatment and advances in technology.Regenerative Therapies in Dry Eye Disease: From Growth Factors to Cell Therapy.Human adipose-derived mesenchymal stem cells can survive and integrate into the adult rat eye following xenotransplantation.Therapeutic Effect of Human Adipose Tissue-Derived Mesenchymal Stem Cells in Experimental Corneal Failure Due to Limbal Stem Cell Niche Damage.Stromal cell-derived factor 1α-stimulated mesenchymal stem cells confer enhanced protection against light-induced retinal degeneration in rats.The Effect of Age on the Regenerative Potential of Human Eyelid Adipose-Derived Stem Cells.Repair of Critical-Sized Rat Calvarial Defects With Three-Dimensional Hydroxyapatite-Gelatin Scaffolds and Bone Marrow Stromal Stem Cells.Ex vivo evaluation of intravitreal mesenchymal stromal cell viability using bioluminescence imaging.
P2860
Q28071279-70C871F9-6D3E-488A-A839-8F610FB24611Q33812258-2AA619E6-84AE-45CA-92F7-79962E2905D1Q33907492-34116950-C285-483F-AFB9-565C6C9071AFQ34022299-F15A68FE-FDE0-46F8-A89E-B4021A3647F4Q35015877-C84C4176-460A-4167-916A-80275428D74DQ35550002-10DFADC0-2BA2-460F-986A-6F1CC4C9B838Q35656032-891D75E6-1512-493C-A6D7-3BC24AE95990Q37033588-F0F3F9DD-5E03-4EA9-B30D-898F6009B014Q37997980-C7FB70DF-B4FA-4CA9-9AC3-618BEE4D3DAAQ38069060-9D2A8620-3AF3-4D32-8934-D0DD092CEEE0Q38138089-F7BD6B8D-E9FD-4753-AAE8-5541A565FED7Q39399611-92B6CD63-F9C7-44B9-AD4B-17CE4B4C3CCFQ42270095-AFF7B8C8-939C-4E6D-8953-760522DC6D38Q43065831-629B3779-8937-48F4-B4ED-99F4D6420F23Q47138584-00BCFBF4-8F2C-4F58-9CC9-9B070BB2A5C9Q48019368-714F5A61-778F-4092-ABCD-356B300AEC98Q48322867-71029113-0BA9-4E9A-AB3E-B7711651B43AQ50472015-D3D21B01-882C-4464-B211-0EC6D7CEEEDCQ54974149-7E62CC55-8EBE-451D-9B53-84B5C726C165Q55031667-540EF86C-6F6B-46E6-AEBF-8BA6F3E9DD61Q55262336-484A36BF-1885-4C21-AB39-E5C2A5BAA036
P2860
Mesenchymal stem cells and potential applications in treating ocular disease.
description
2010 nî lūn-bûn
@nan
2010年の論文
@ja
2010年学术文章
@wuu
2010年学术文章
@zh-cn
2010年学术文章
@zh-hans
2010年学术文章
@zh-my
2010年学术文章
@zh-sg
2010年學術文章
@yue
2010年學術文章
@zh
2010年學術文章
@zh-hant
name
Mesenchymal stem cells and potential applications in treating ocular disease.
@en
Mesenchymal stem cells and potential applications in treating ocular disease.
@nl
type
label
Mesenchymal stem cells and potential applications in treating ocular disease.
@en
Mesenchymal stem cells and potential applications in treating ocular disease.
@nl
prefLabel
Mesenchymal stem cells and potential applications in treating ocular disease.
@en
Mesenchymal stem cells and potential applications in treating ocular disease.
@nl
P2860
P1433
P1476
Mesenchymal stem cells and potential applications in treating ocular disease.
@en
P2093
Aaron W Joe
Kevin Gregory-Evans
P2860
P304
P356
10.3109/02713683.2010.516466
P577
2010-11-01T00:00:00Z